NCT04340518 is a NA clinical trial of Scleral lens in Conjunctival Diseases, sponsored by University of Houston.

Who is sponsoring NCT04340518?

NCT04340518 is sponsored by University of Houston.

What drugs are being tested in NCT04340518?

Interventions in NCT04340518: Scleral lens.

What condition does NCT04340518 study?

NCT04340518 studies Conjunctival Diseases.

Is NCT04340518 still recruiting?

NCT04340518 is currently completed. Last updated 29 January 2021.

Last reviewed 2021-01-29 · How we verify

NCT04340518

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Conjunctival Rebound After Scleral Lens Wear

Completed NA Last updated 29 January 2021

What this trial tests

NA trial testing Scleral lens in Conjunctival Diseases in 13 participants. Completed in 30 May 2020.

Timeline

1 December 2019

Primary endpoint
1 May 2020

30 May 2020

Quick facts

Lead sponsor	University of Houston
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	13
Start date	1 December 2019
Primary completion	1 May 2020
Estimated completion	30 May 2020
Sites	1 location across United States

Drugs / interventions tested

Scleral lens

Conditions studied

Conjunctival Diseases — all drugs for Conjunctival Diseases →

Sponsor

University of Houston

Who can join

Adults 18 to 80, any sex, with Conjunctival Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Scleral lenses, customized rigid contact lenses that land on the soft and spongy conjunctival tissue overlying the sclera, will be fitted on 15 subjects with normal ocular surfaces. The purpose of the study is to determine the amount of conjunctival compression caused by the devices and the length of time required for the shape to recover from compression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Houston trials

Trials by the same sponsor.

NCT07024992 — Enhancing Smoking Cessation for African American People Everywhere · Phase 2 · not yet recruiting
NCT07025772 — Shaping Habitual Impulses For a Tobacco-free Style · NA · recruiting
NCT07007195 — Smart Olfaction App to Reduce Relapse · EARLY_PHASE1 · not yet recruiting
NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting
NCT07227220 — Summer Youth Employment Programs for Health Promotion · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04340518 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Houston
Last refreshed: 29 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04340518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing